Steven Cohen’s AC Immune ACIU Stock Holding History

Steven Cohen’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-293,200	Closed	-$806K	–	3931
2026 Q1	$806K	Buy	293,200 +265,300	+951%	+$824K	﹤0.01%	2886
2025 Q4	$87.6K	Buy	+27,900	New	+$88K	﹤0.01%	3752

Other funds holding ACIU

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Steven Cohen's ACIU Position: Q1 2026 in Review

Steven Cohen sold out of AC Immune (ACIU) in Q1 2026, closing a stake of 384,845 shares — an estimated $1.2M sold.

Steven Cohen first reported a position in ACIU in Q3 2016 and held it in 4 quarters. The position peaked at $2.99M in Q2 2021. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

Steven Cohen reported no remaining AC Immune position as of Q1 2026 after selling out during the quarter.
Steven Cohen sold 384,845 AC Immune shares in Q1 2026, an estimated $1.2M.
Steven Cohen first reported a position in AC Immune in Q3 2016 and held it in 4 quarters.
Steven Cohen's AC Immune position peaked at $2.99M in Q2 2021.
46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.